| [1] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17–48.
|
| [2] |
Wang FH, Zhang XT, Tang L, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023[J]. Cancer Commun (Lond), 2024, 44(1): 127–172.
|
| [3] |
Huang B, Sunde B, Tsekrekos A, et al. Partial stomach-partitioning gastrojejunostomy for gastric outlet obstruction: A cohort study based on consecutive case series from a single center[J]. Asian J Surg, 2022, 45(1): 326–331.
|
| [4] |
Lyons J, Marks J. To cut or not to cut; that is the question: surgical versus endoscopic gastrojejunostomy for the palliation of malignant gastric outlet obstruction[J]. Gastrointest Endosc, 2023, 98(3): 360–361.
|
| [5] |
Chan SM, Dhir V, Chan YYY, et al. Endoscopic ultrasound-guided balloon-occluded gastrojejunostomy bypass, duodenal stent or laparoscopic gastrojejunostomy for unresectable malignant gastric outlet obstruction[J]. Dig Endosc, 2023, 35(4): 512–519.
|
| [6] |
黎介寿, 吴孟超, 黄志强. 普通外科手术学[M]. 3版. 北京: 人民军医出版社, 2022: 123–145.
|
| [7] |
Kwok SP, Chung SC, Griffin SM, et al. Devine exclusion for unresectable carcinoma of the stomach[J]. Br J Surg, 1991, 78(6): 684–685.
|
| [8] |
Kaminishi M, Yamaguchi H, Shimizu N, et al. Stomach-partitioning gastrojejunostomy for unresectable gastric carcinoma[J]. Arch Surg, 1997, 132(2): 184–187.
|
| [9] |
Japanese Gastric Cancer Association. Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)[J]. Gastric Cancer, 2023, 26(1): 1–25.
|
| [10] |
Matsumoto T, Izumi K, Shiromizu A, et al. Laparoscopic gastric partitioning gastrojejunostomy for an unresectable duodenal malignant tumor[J]. J Minim Access Surg, 2005, 1(3): 129–132.
|
| [11] |
Hirahara N, Matsubara T, Hyakudomi R, et al. Laparoscopic stomach-partitioning gastrojejunostomy with reduced-port techniques for unresectable distal gastric cancer[J]. J Laparoendosc Adv Surg Tech A, 2014, 24(3): 177–182.
|
| [12] |
Tanaka T, Suda K, Satoh S, et al. Effectiveness of laparoscopic stomach-partitioning gastrojejunostomy for patients with gastric outlet obstruction caused by advanced gastric cancer[J]. Surg Endosc, 2017, 31(1): 359–367.
|
| [13] |
Ojima T, Nakamori M, Nakamura M, et al. Laparoscopic gastrojejunostomy for patients with unresectable gastric cancer with gastric outlet obstruction[J]. J Gastrointest Surg, 2017, 21(8): 1220–1225.
|
| [14] |
Suzuki O, Shichinohe T, Yano T, et al. Laparoscopic modified Devine exclusion gastrojejunostomy as a palliative surgery to relieve malignant pyloroduodenal obstruction by unresectable cancer[J]. Am J Surg, 2007, 194(3): 416–418.
|
| [15] |
Liu H, Xu Q, Ma FH, et al. The clinical value of totally laparoscopic stomach-partitioning gastrojejunostomy for malignant gastric outlet obstruction[J]. Zhonghua Zhong Liu Za Zhi, 2020, 42(6): 445–448.
|
| [16] |
Tsuchiya T, Itoi T, Ishii K, et al. Long-term outcomes of EUS-guided balloon-occluded gastrojejunostomy bypass for malignant gastric outlet obstruction (with video)[J]. Gastrointest Endosc, 2025, 101(1): 195–199.
|
| [17] |
Tanaka T, Suda K, Nakauchi M, et al. Safety and feasibility of laparoscopic stomach-partitioning gastrojejunostomy combined with neoadjuvant chemotherapy followed by minimally invasive gastrectomy for resectable gastric cancer with gastric outlet obstruction[J]. Surg Endosc, 2025, 39(2): 837–849.
|
| [18] |
Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives[J]. J Hematol Oncol, 2023, 16(1): 57.
|
| [19] |
Cawood AL, Burden ST, Smith T, et al. A systematic review and meta-analysis of the effects of community use of oral nutritional supplements on clinical outcomes[J]. Ageing Res Rev, 2023, 88: 101953.
|
| [20] |
Shao XX, Xu Q, Wang BZ, et al. Modified stomach-partitioning gastrojejunostomy for initially unresectable advanced gastric cancer with outlet obstruction: A case report[J]. World J Gastrointest Surg, 2023, 15(6): 1247–1255.
|
| [21] |
Tanaka C, Kanda M, Misawa K, et al. Long-term quality of life after open and laparoscopic total gastrectomy for stage Ⅰ gastric cancer: A prospective multi-institutional study (CCOG1504)[J]. Ann Gastroenterol Surg, 2024, 8(6): 999–1007.
|
| [22] |
Deng YY, Jiang DY, Zhu PF, et al. Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: A retrospective cohort study[J]. World J Surg Oncol, 2023, 21(1): 129.
|
| [23] |
Serra F, Pedrazzoli P, Brugnatelli S, et al. Nutritional support management in resectable gastric cancer[J]. Drugs Context, 2022, 11: 2022–5-1.
|
| [24] |
Guchelaar NAD, Nasserinejad K, Mostert B, et al. Intraperitoneal chemotherapy for peritoneal metastases of gastric origin: A systematic review and meta-analysis[J]. Br J Surg, 2024, 111(5): znae116.
|